23:38 , Sep 25, 2017 |  BC Extra  |  Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

On Monday, cancer company Fusion Pharmaceuticals Inc. (Hamilton, Ontario), single-cell analytics company IsoPlexis Corp. (Branford, Conn.) and health analytics company Tempus Labs (Chicago, Ill.) announced venture financings, raising over $100 million. Fusion raised $21 million...
19:31 , Mar 31, 2017 |  BC Week In Review  |  Financial News

Promentis completes venture financing

Neurology company Promentis Pharmaceuticals Inc. (Milwaukee, Wisc.) raised $26 million in a series C round led by new investors OrbiMed, F-Prime Capital and Aisling Capital on March 30. Existing investors Black Pearl, the Golden Angel...
16:33 , Mar 30, 2017 |  BC Extra  |  Financial News

Promentis raises $26M in series C

Promentis Pharmaceuticals Inc. (Milwaukee, Wisc.) raised $26 million in a series C round led by new investors OrbiMed, F-Prime Capital and Aisling Capital . Existing investors Black Pearl GmbH, the Golden Angel Network and individual...
08:00 , Jan 27, 2014 |  BC Week In Review  |  Financial News

Promentis Pharmaceuticals completes venture financing

Promentis Pharmaceuticals Inc. , Milwaukee, Wis.   Business: Neurology   Date completed: 1/21/14   Type: Venture financing   Raised: $2.9 million   Investors: Black Horse Investments; Golden Angel Investors; private investors  ...
07:00 , Aug 5, 2013 |  BC Week In Review  |  Company News

Promentis Pharmaceuticals management update

Promentis Pharmaceuticals Inc. , Milwaukee, Wis.   Business: Neurology   Hired: Chad Beyer as president and CEO  ...